Therefore we propose that a subset of tumor cells that receives a sublethal hit from the drug is sensitized for apoptosis by agonistic anti-TRAIL-R (DR5) antibodies or tumor-specific CD8 T cells and most likely also NK cells. This evidence concerns the gene CD8A and neoplasm.